Skip to main content
Log in

Hirntumoren und Epilepsien

Brain tumors and epilepsy

  • Übersicht
  • Published:
Zeitschrift für Epileptologie Aims and scope Submit manuscript

Zusammenfassung

Verbesserte Tumor- und Epilepsiebehandlungsmöglichkeiten führen heute zu vermehrter Langzeitbetreuung von Patienten mit tumorbedingten Epilepsien. Im folgenden Beitrag werden pathophysiologische und epidemiologische Aspekte, Fortschritte in der Diagnose und medikamentöse sowie epilepsiechirurgische Therapieansätze vorgestellt. Hierbei wird besonders auf die Anfallskontrolle, Therapienebenwirkungen und die Lebensqualität der Patienten eingegangen. Durch die Langzeitbetreuung, die häufig über 10 bis 20 Jahre hinweg notwendig wird, stehen individuell optimale Therapiestrategien im Vordergrund. Diese sollten sich an neuen elektrophysiologischen Verfahren, wie z. B. Magnetresonanztomographie (MRT) und Magnetoenzephalographie (MEG), orientieren sowie Wechselwirkungen zwischen Antikonvulsiva und Chemotherapeutika beachten.

Abstract

Today’s improved tumor and epilepsy treatment possibilities have led to increased numbers of long-term care patients with symptomatic epilepsies caused by tumors. Pathophysiology, epidemiology, advancements in diagnosis, drug as well as surgical treatments are discussed with special emphasis being placed on seizure control, side effects, and quality of life. Because long-term care – often 10 to 20 years – is necessary, optimal individual treatment strategies have to be selected. New electrophysiological techniques, e.g., magnetic resonance imaging (MRI) and magnetic encephalography (MEG), as well as the interaction of anticonvulsive and chemo-therapeutic drugs should be taken into account.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Blümcke I, Luyken C, Urbach H et al (2004) An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis. Acta Neuropathol 107:381–388

    Article  PubMed  Google Scholar 

  2. Boarini D, Beck D, Van Gilder J (1985) Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 16:290–292

    Article  CAS  PubMed  Google Scholar 

  3. Blume WT, Girvin JP, Kaufmann JC (1982) Childhood brain tumors presenting as chronic, uncontrolled seizure disorders. Ann Neurol 12:538–541

    Article  CAS  PubMed  Google Scholar 

  4. Boon PA, Williamson PD, Fried I et al (1991) Intracranial, intraaxial, space-occupying lesions in patients with intractable partial seizures: an anatomoclinical, neuropsychological and surgical correlation. Epilepsia 32:467–476

    Article  CAS  PubMed  Google Scholar 

  5. Britton JW, Cascino GD, Sharbrough FW, Kelly PJ (1994) Low-grade glial neoplasms and intractable partial epilepsy: efficacy of surgical treatment. Epilepsia 35:1130–1135

    Article  CAS  PubMed  Google Scholar 

  6. Buchfelder M, Fahlbusch R, Ganslandt O et al (2002) Use of intraoperative magnetic resonance imaging in tailored temporal lobe surgeries for epilepsy. Epilepsia 43:864–873

    Article  PubMed  Google Scholar 

  7. Delattre JY, Krol G, Thaler HT, Posner JB (1988) Distribution of brain metastases. Arch Neurol 45:741–744

    CAS  PubMed  Google Scholar 

  8. Forsyth P, Weaver S, Fullon D et al (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30:106–112

    PubMed  Google Scholar 

  9. Gattis W, May D (1996) Possible interaction involving phenytoin, dexamethasone and antineoplastic agents. Ann Pharmacother 30:520–526

    CAS  PubMed  Google Scholar 

  10. Gilbar P, Brodribb T (2001) Phenytoin and fluorouracil interaction. Ann Pharmacother 35:1367–1370

    Article  CAS  PubMed  Google Scholar 

  11. Gilham R, Kane K, Bryant-Comstock L, Brodie M (2000) A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 9:375–379

    Article  Google Scholar 

  12. Glantz M, Cole B, Forsyth P et al (2000) Practice parameter: anticonvulsant prophylaxis with newly diagnosed brain tumors. Neurology 54:1886–1893

    CAS  PubMed  Google Scholar 

  13. Gunnarsson T, Olafsson E, Sighvatsson V, Hannesson B (2002) Surgical treatment of patients with low-grade astrocytomas and medically intractable seizures. Acta Neurol Scand 105:289–292

    Article  CAS  PubMed  Google Scholar 

  14. Hammen T, Stefan H (2004) 1H-MR-Spektroskopie: Methoden und Anwendung in der Diagnostik und Beurteilung operativer und konservativer Therapiestrategien bei Epilepsien. Nervenarzt 75(9):970–983

    Article  CAS  PubMed  Google Scholar 

  15. Harting I, Jost G, Hacke N, Hartmann M (2004) Magnetresonanz-Spektroskopie von Hirntumoren. Nervenarzt 76(4):403–417

    Article  Google Scholar 

  16. Ibrahim K, Appleton R (2004) Seizures as the presenting symptom of brain tumours in children. Seizure 13:108–112

    Article  PubMed  Google Scholar 

  17. Ketter T, Post R, Theodore W (1999) Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 53 [Suppl 2]:53–67

  18. Klein M, Klein M, Engelberts N et al (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514–520

    Article  PubMed  Google Scholar 

  19. Le Blanc F, Rasmussen T (1974) Cerebral seizures and brain tumors. In: Vinken P, Bruyn G (eds) Handbook of clinical neurology. Elsevier, New York, pp 295–301

  20. Löscher W (2002) Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Signs 23:113–118

    Article  Google Scholar 

  21. Luyken C, Blümcke I, Fimmers R et al (2003) The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44:822–830

    Article  PubMed  Google Scholar 

  22. Maehara T, Nariai T, Arai N et al (2004) Usefulness of (11C) methionine PET in the diagnosis of dysembryoplastic neuroepithelial tumor with temporal lobe epilepsy. Epilepsia 45:41–45

    Article  PubMed  Google Scholar 

  23. Mason WP (2003) Anticonvulsant prophylaxis for patients with brain tumours: insights from clinical trials. Can J Neurol Sci 30:89–90

    PubMed  Google Scholar 

  24. Moots P, Maciunas R, Eisert D et al (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52:717–724

    CAS  PubMed  Google Scholar 

  25. Nimsky C, Ganslandt O, Fahlbusch R (2004) Functional neuronavigation and intraoperative MRI. Adv Tech Stand Neurosurg 29:229–263

    CAS  PubMed  Google Scholar 

  26. Penfield W, Jasper H (1954) Epilepsy and the functional anatomy of the human brain, Little Brown, Boston p 774

  27. Piepmeier J (1987) Observations on the current treatment of low-grade astrocytic tumours of the cerebral hemispheres. J Neurosurg 67:177–181

    Article  CAS  PubMed  Google Scholar 

  28. Relling MV, Ching-Hon P, Sandlund JT et al (2000) Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 356:285–290

    Article  CAS  PubMed  Google Scholar 

  29. Schramm J, Luyken C, Urbach H, Fimmers R (2004) Evidence for a clinical distinct new subtype of grade II astrocytomas in patients with long-term epilepsy. Neurosurgery 55:340–348

    Article  PubMed  Google Scholar 

  30. Stefan H, Hammen T (2004) Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand 110:393–397

    Article  CAS  PubMed  Google Scholar 

  31. Telfeian AE, Philips MF, Crino PB, Judy KD (2001) Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme. J Exp Clin Cancer Res 20:5–10

    CAS  PubMed  Google Scholar 

  32. Trimble M, Schmitz B (2002) The neuropsychiatry of epilepsy. Cambridge University Press, Cambridge

  33. Vecht C, Wagner G, Wilms E (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet 2:404–408

    Article  CAS  Google Scholar 

  34. Villemure JG, de Tribolet N (1996) Epilepsy in patients with central nervous system tumors. Curr Opin Neurol 9:424–428

    Article  CAS  PubMed  Google Scholar 

  35. Villikka K, Kivistö K, Mäenpää H et al (1999) Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin Pharmacol Ther 66:589–593

    CAS  PubMed  Google Scholar 

  36. Wagner GL, Wilms EB, van Donselaar CA et al (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585–596

    Article  CAS  PubMed  Google Scholar 

  37. Wang Y, Zhou D, Wang B et al (2003) A kindling model of pharmacoresistant temporal lobe epilepsy in Sprague-Dawley rats induced by Coriaria lactone and its possible mechanism. Epilepsia 44:475–488

    Article  PubMed  Google Scholar 

  38. White JC, Liu CT, Mixter WJ (1948) Focal epilepsy: a statistical study of its causes and the results of surgical treatment. I. Epilepsy secondary to intracranial tumors. N Engl J Med 438:891–899

    Article  Google Scholar 

  39. Wyllie E, Lüders H, Morris HH (1987) Clinical outcome after complete or partial resection for intractable epilepsy. Neurology 37:1634–1641

    CAS  PubMed  Google Scholar 

  40. Zentner J, Hufnagel A, Wolf H (1997) Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 41:378–387

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Stefan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stefan, H. Hirntumoren und Epilepsien. Z. Epileptol. 22, 65–71 (2009). https://doi.org/10.1007/s10309-009-0032-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10309-009-0032-2

Schlüsselwörter

Keywords

Navigation